Jill Feldman, Lung cancer Patient and Advocate, Co-Founder of EGFR Resisters, shared a post on X:
“Operable is a clinical label, and doesn’t always mean the ‘right’ choice. The right decision depends on the life a person wants to live after treatment.
When treatments are comparable, the decisions must center on what matters most to patients, which is why honest, nuanced, informed conversations are critical.Patient preferences should always guide treatment decisions.”
Shankar Siva, Radiation Oncologist at the Peter MacCallum Cancer Centre, shared this post, adding:
“To all of you there who treat lung cancer, and to my medical oncology friends in particular who have followed the ‘big pharma’ terminology – this word is a major issue cancer care….
LCSM great article here.”
More posts featuring Jill Feldman on OncoDaily.